NO20024645D0 - Små kuler med vedvarende frigjöring inneholdende stavudin - Google Patents

Små kuler med vedvarende frigjöring inneholdende stavudin

Info

Publication number
NO20024645D0
NO20024645D0 NO20024645A NO20024645A NO20024645D0 NO 20024645 D0 NO20024645 D0 NO 20024645D0 NO 20024645 A NO20024645 A NO 20024645A NO 20024645 A NO20024645 A NO 20024645A NO 20024645 D0 NO20024645 D0 NO 20024645D0
Authority
NO
Norway
Prior art keywords
sustained release
small spheres
release containing
stavudine
containing stavudine
Prior art date
Application number
NO20024645A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024645L (no
Inventor
Robert Abramowitz
Denise M O'donoghue
Nemichand B Jain
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20024645L publication Critical patent/NO20024645L/no
Publication of NO20024645D0 publication Critical patent/NO20024645D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20024645A 2000-03-30 2002-09-27 Små kuler med vedvarende frigjöring inneholdende stavudin NO20024645D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19358800P 2000-03-30 2000-03-30
PCT/US2001/010078 WO2001074329A2 (en) 2000-03-30 2001-03-29 Sustained release beadlets containing stavudine

Publications (2)

Publication Number Publication Date
NO20024645L NO20024645L (no) 2002-09-27
NO20024645D0 true NO20024645D0 (no) 2002-09-27

Family

ID=22714247

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024645A NO20024645D0 (no) 2000-03-30 2002-09-27 Små kuler med vedvarende frigjöring inneholdende stavudin

Country Status (26)

Country Link
US (1) US7135465B2 (cs)
EP (1) EP1267879A2 (cs)
JP (1) JP2003528905A (cs)
KR (1) KR20030011805A (cs)
CN (1) CN1187052C (cs)
AR (1) AR027748A1 (cs)
AU (1) AU2001249591A1 (cs)
BG (1) BG107157A (cs)
BR (1) BR0109602A (cs)
CA (1) CA2404687A1 (cs)
CZ (1) CZ20023003A3 (cs)
EE (1) EE200200564A (cs)
GE (1) GEP20043285B (cs)
HU (1) HUP0302631A2 (cs)
IL (1) IL151475A0 (cs)
LT (1) LT5045B (cs)
LV (1) LV12939B (cs)
MX (1) MXPA02009534A (cs)
NO (1) NO20024645D0 (cs)
NZ (1) NZ522250A (cs)
PE (1) PE20011179A1 (cs)
PL (1) PL366089A1 (cs)
RU (1) RU2239435C2 (cs)
SK (1) SK12822002A3 (cs)
WO (1) WO2001074329A2 (cs)
ZA (1) ZA200207760B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
MXPA05000018A (es) * 2002-06-27 2005-04-08 Cilag Ag Formulaciones de pellas esfericas.
CA2529984C (en) * 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
CN100548309C (zh) * 2004-11-24 2009-10-14 东北制药总厂 司他夫定缓释片剂
TW201414495A (zh) 2005-04-04 2014-04-16 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
JP2008543845A (ja) * 2005-06-16 2008-12-04 フォーレスト ラボラトリーズ， インコーポレイテッド 放出調節および即放性メマンチンビーズ製剤
AU2006286314A1 (en) * 2005-08-31 2007-03-08 Cipla Limited Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
GB0525461D0 (en) 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
AU2007206901B2 (en) 2006-01-20 2013-01-31 Janssen Sciences Ireland Uc Long term treatment of HIV- infection with TCM278
CA2648278C (en) * 2006-04-03 2019-05-28 Isa Odidi Drug delivery composition
CN104825397A (zh) * 2006-04-03 2015-08-12 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
CL2008000746A1 (es) 2007-03-14 2008-09-22 Tibotec Pharm Ltd Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida.
CN102319181B (zh) * 2011-09-08 2014-07-16 广东大华农动物保健品股份有限公司 一种微囊型动物药品的包被工艺
US20140271893A1 (en) * 2013-03-15 2014-09-18 Mcneil-Ppc, Inc. Coated phenylephrine particles and use thereof in pharmaceutical formulations
EP3169314A1 (en) * 2014-07-17 2017-05-24 Dow Global Technologies LLC Ethylcellulose dispersion and film
CN105511174A (zh) * 2016-01-05 2016-04-20 深圳市华星光电技术有限公司 液晶显示面板和显示装置

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671963A (en) * 1983-10-28 1987-06-09 Germino Felix J Stearate treated food products
US4670270A (en) * 1984-05-07 1987-06-02 Germino Felix J Stearate treated food products
US4940556A (en) 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
JP2628230B2 (ja) 1991-12-30 1997-07-09 エフ エム シー コーポレーション 微結晶性セルローススフェロニゼーション組成物
US5472711A (en) 1992-07-30 1995-12-05 Edward Mendell Co., Inc. Agglomerated hydrophilic complexes with multi-phasic release characteristics
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
FI101039B (fi) 1992-10-09 1998-04-15 Eeva Kristoffersson Menetelmä lääkepellettien valmistamiseksi
US5869097A (en) * 1992-11-02 1999-02-09 Alza Corporation Method of therapy comprising an osmotic caplet
GB9403449D0 (en) 1994-02-23 1994-04-13 Wellcome Found Therapeutic benzonitriles
DK0749421T3 (da) 1994-03-07 2000-03-20 Vertex Pharma Sulfonamidderivater som aspartylproteaseinhibitorer
GB9417249D0 (en) * 1994-08-26 1994-10-19 Wellcome Found A novel salt
AU702422B2 (en) 1995-02-23 1999-02-18 Janssen Pharmaceutica N.V. Use of fused benzothiazoles as neuroprotectants
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5691372A (en) 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
PL327199A1 (en) 1995-12-15 1998-11-23 Cryopreservation Tech Cc Composition for cryopreservation of body organs and for treating viral and bacterial infections
SE9600072D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
US5883252A (en) 1996-01-26 1999-03-16 Vertex Pharmaceuticals Incorporated Aspartyl protease inhibitors
US5766623A (en) * 1996-03-25 1998-06-16 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Compactable self-sealing drug delivery agents
US5849911A (en) 1996-04-22 1998-12-15 Novartis Finance Corporation Antivirally active heterocyclic azahexane derivatives
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
US5905068A (en) 1996-09-24 1999-05-18 Abbott Laboratories Retroviral protease inhibiting compounds
WO1998018452A1 (en) 1996-10-25 1998-05-07 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
US5962462A (en) 1996-12-13 1999-10-05 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
US5919776A (en) 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
US6124319A (en) 1997-01-21 2000-09-26 Merck & Co., Inc. 3,3-disubstituted piperidines as modulators of chemokine receptor activity
US6136827A (en) 1997-07-25 2000-10-24 Merck & Co., Inc. Cyclic amine modulations of chemokine receptor activity
PT1003476E (pt) 1997-08-11 2005-05-31 Alza Corp Forma de dosagem de agente activo de libertacao prolongada adaptada para retencao gastrica
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
EP1028712B1 (en) * 1997-09-19 2005-01-12 Shire Laboratories Inc. Solid solution beadlet
US5904937A (en) 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US6180634B1 (en) 1997-11-13 2001-01-30 Merck & Co., Inc. Combination therapy for the treatment of AIDS
US6013644A (en) 1997-12-12 2000-01-11 Merck & Co., Inc. Spiro-substituted azacycles as modulators of chemokine receptor activity
EP1039899A2 (en) 1997-12-19 2000-10-04 Takeda Chemical Industries, Ltd. Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative
US6140349A (en) 1998-02-02 2000-10-31 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition
US6093743A (en) 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
WO1999066936A1 (en) 1998-06-24 1999-12-29 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
JP2002540151A (ja) 1999-03-31 2002-11-26 ザ プロクター アンド ギャンブル カンパニー ウイルス治療
US6136835A (en) 1999-05-17 2000-10-24 The Procter & Gamble Company Methods of treatment for viral infections

Also Published As

Publication number Publication date
WO2001074329A2 (en) 2001-10-11
NO20024645L (no) 2002-09-27
HUP0302631A2 (hu) 2003-11-28
LT5045B (lt) 2003-08-25
RU2002126540A (ru) 2004-03-27
EP1267879A2 (en) 2003-01-02
CN1187052C (zh) 2005-02-02
PL366089A1 (en) 2005-01-24
BR0109602A (pt) 2004-06-29
WO2001074329A3 (en) 2002-05-10
MXPA02009534A (es) 2003-05-14
BG107157A (en) 2003-06-30
IL151475A0 (en) 2003-04-10
CN1420774A (zh) 2003-05-28
SK12822002A3 (sk) 2003-02-04
NZ522250A (en) 2004-09-24
LT2002099A (en) 2003-04-25
ZA200207760B (en) 2004-01-30
AR027748A1 (es) 2003-04-09
RU2239435C2 (ru) 2004-11-10
CA2404687A1 (en) 2001-10-11
US7135465B2 (en) 2006-11-14
LV12939B (en) 2003-04-20
CZ20023003A3 (cs) 2002-11-13
US20020002147A1 (en) 2002-01-03
JP2003528905A (ja) 2003-09-30
KR20030011805A (ko) 2003-02-11
GEP20043285B (en) 2004-07-26
AU2001249591A1 (en) 2001-10-15
PE20011179A1 (es) 2001-12-06
EE200200564A (et) 2004-06-15

Similar Documents

Publication Publication Date Title
NO20024645D0 (no) Små kuler med vedvarende frigjöring inneholdende stavudin
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20024270D0 (no) Vedvarende frigivelsesranolazinformuleringer
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
AR028106A1 (es) Formulaciones de glifosato de potasio
IS6709A (is) Fljótandi samsetningar metformíns
FR2805450B1 (fr) Hysteroscope
ID30187A (id) Dongkrak jenis pantagraf
PT1250321E (pt) Composicao de gliburida
DK1142477T3 (da) Sammensætninger med reguleret frigivelse
DE50106120D1 (de) Kolbenfreistellung
DE60122229D1 (de) Trennfilm
DE60107787D1 (de) Wässrige Zusammensetzung aus Emulsionsacryl-polymeren
DE60135023D1 (de) Trennmittelzusammensetzung
DE50213834D1 (de) Trennmittel
FI20002120A0 (fi) Sammutin
FI20000526A0 (fi) Preassurans-sammutusjärjestelmä
DE10082489D2 (de) Ausrücksystem
FI20000981A0 (fi) 'Vaahtosammutin
UA4579S (uk) Дозиметр-радіометр гамма-бета-випромінювань
DE60124221D1 (de) MONOHYDRAT DES CIS-LITHIUM-CYANO-4-i3-(CYCLOPENTYLOY)-4-METHOXYPHENYLöCYCLOHEXANCARBOXYLATS
FI20002526A7 (fi) Pyridatsinonijohdannaisten uusi käyttö
SE0004003D0 (sv) Synthesis of FLG
ITMI20000110V0 (it) Struttura di riloga
SE0001704L (sv) Såbill

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application